The correlation between serum resistin and toll-like receptor-4 with insulin resistance in hypertensive subjects with or without type 2 diabetes mellitus
DOI:
https://doi.org/10.47419/bjbabs.v2i04.70Keywords:
hypertension, insulin resistance, resistin, TLR4, type 2 diabetes mellitusAbstract
Background: The most chronic disease prevalence in the Iraqi population are type-2 diabetes mellitus (T2DM) and hypertension (HT). One of the important causes of these chronic diseases is obesity. Resistin (RETN) is a major link between obesity and insulin resistance (IR) or T2DM (which induces IR). The action of RETN on IR is mediated by Toll-like receptor-4 (TLR4). TLR4 is a putative RETN receptor that has been suggested to participate in RETN-inducing inflammation and IR.
Objectives: To study the association between serum RETN/TLR4 and IR in hypertensive patients with or without T2DM subjects.
Methods: This cross-sectional study was conducted on 120 men that classified into four different groups. These groups consist of the following: 30 apparently control group, 30 patients with hypertension, 30 patients with T2DM but without HT and 30 hypertensive patients with T2DM. For all the subjects, serum RETN, TLR4 and serum insulin was estimated by using the ELISA technique.
Results: Our results showed that mean levels of the serum RETN and TLR4 were significantly elevated in all patient groups when compared with the control group. Also, a positive correlation between serum RETN and TLR4 was found in hypertensive patients with T2DM patients.
Conclusions: Serum RETN and TLR4 were higher in all patient groups when compared with the control group. In addition, a positive correlation between RETN and IR in all study groups was noted. Then, we suggested a close association between RETN and TLR4 and their positive correlations with IR.
Metrics
Downloads
References
A Schaeffler et al. “Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-κB pathway in adipocytes links nutritional signalling with innate immunity”. Immunology 126(2) (2009), pp. 233–245. DOI: https://doi.org/10.1111/j.1365-2567.2008.02892.x. DOI: https://doi.org/10.1111/j.1365-2567.2008.02892.x
A Urbanovych. “The blood resistin level in patients with DM2, depending on the duration of the disease”. Curr Issues Pharm Med Sci 28(2) (2015), pp. 111–114. DOI: https://doi.org/10.1515/cipms-2015-0055. DOI: https://doi.org/10.1515/cipms-2015-0055
American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. 2020. DOI: https://doi.org/10.2337/dc20-S002. DOI: https://doi.org/10.2337/dc20-S002
D Matthews et al. “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man”. Diabetologia 28 (1985), pp. 412–419. DOI: https://doi.org/10.1007/BF00280883
Elina Malo et al. “Resistin is an indicator of the metabolic syndrome according to five different definitions in the Finnish Health 2000 survey”. Metab Syndr Relat Disord 9(3) (2011), pp. 203–213. DOI: https://doi.org/10.1089/met.2010.0106.
F Kim et al. “Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity”. Circ Res 100(11) (2007), pp. 1589–1596. DOI: https://doi.org/10.1161/CIRCRESAHA.106.142851. DOI: https://doi.org/10.1161/CIRCRESAHA.106.142851
Francesco Peri and Matteo Piazza. “Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists”. Biotechnol Adv 30 (2012), pp. 251–260. DOI: https://doi.org/10.1016/j.biotechadv.2011.05.014. DOI: https://doi.org/10.1016/j.biotechadv.2011.05.014
J C Levy, D R Matthews, and M P Hermans. “Correct homeostasis model assessment (HOMA) evaluation uses the computer program”. Diabetes care 21(12) (1998), pp. 2191–2192. DOI: https://doi.org/10.2337/diacare.21.12.2191. DOI: https://doi.org/10.2337/diacare.21.12.2191
Khalid Siddiqui, Salini Scaria Joy, and Teena P. George. “Circulating resistin levels in relation with insulin resistance, inflammatory and endothelial dysfunction markers in patients with type 2 diabetes and impaired fasting glucose”. Endocr Metab Sci 1(3-4) (2020), p. 100059. DOI: https://doi.org/10.1016/j.endmts.2020.100059. DOI: https://doi.org/10.1016/j.endmts.2020.100059
Komal Rawal et al. “Resistin mitigates stemness and metabolic profile of human adipose-derived mesenchymal stem cells via insulin resistance”. Cytokine 138 (2021). DOI: https://doi.org/10.1016/j.cyto.2020.155374. DOI: https://doi.org/10.1016/j.cyto.2020.155374
L K Heilbronn et al. “Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects”. J Clin Endocrinol Metab 89(4) (2004), pp. 1844–1848. DOI: https://doi.org/10.1210/jc.2003-031410. DOI: https://doi.org/10.1210/jc.2003-031410
M Gutch et al. “Assessment of insulin sensitivity/resistance”. Indian J Endocrinol Metab 19(1) (2015), pp. 160–164. DOI: https://doi.org/10.4103/2230-8210.146874. DOI: https://doi.org/10.4103/2230-8210.146874
Md S Jamaluddin et al. “Resistin: functional roles and therapeutic considerations for cardiovascular disease”. Br J Pharmacol 165(3) (2012), pp. 622–632. DOI: https://doi.org/10.1111/j.1476-5381.2011.01369.x. DOI: https://doi.org/10.1111/j.1476-5381.2011.01369.x
Mengxue Yang et al. “Effects of serum from the obesity patients with diabetic mellitus on TLR4/NF-κB pathway in human THP-1 monocytes”. Zhong Nan Da Xue Xue Bao Yi Xue Ban 39(9) (2014), pp. 917–923. DOI: https://doi.org/10.11817/j.issn.1672-7347.2014.09.009.
Naglaa Azab et al. “Correlation of serum resistin level with insulin resistance and severity of retinopathy in type 2 diabetes mellitus”. J Saudi Chem Soc 20(3) (2016), pp. 272–277. DOI: https://doi.org/10.1016/j.jscs.2012.07.003. DOI: https://doi.org/10.1016/j.jscs.2012.07.003
O A Mojiminiyi and N A Abdella. “Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus”. Scand J Clin Lab Invest 67(2) (2007), pp. 215–225. DOI: https://doi.org/10.1080/00365510601032532. DOI: https://doi.org/10.1080/00365510601032532
Patricia C Underwood and Gail K Adler. “The renin angiotensin aldosterone system and insulin resistance in humans”. Curr Hypertens Rep 15(1) (2013), pp. 59–70. DOI: https://doi.org/10.1007/s11906-012-0323-2. DOI: https://doi.org/10.1007/s11906-012-0323-2
Rahul B Dange et al. “Central blockade of TLR4 improves cardiac function and attenuates myocardial inflammation in angiotensin II-induced hypertension”. Cardiovasc Res 103(1) (2014), pp. 17–27. DOI: https://doi.org/10.1093/cvr/cvu067. DOI: https://doi.org/10.1093/cvr/cvu067
S Banu et al. “Correlation of Toll-like receptor 4, interleukin-18, transaminases, and uric acid in patients with chronic periodontitis and healthy adults”. J Periodontol 86(3) (2015), pp. 431–440. DOI: https://doi.org/10.1902/jop.2014.140414. DOI: https://doi.org/10.1902/jop.2014.140414
S C Harwani et al. “Neurohormonal modulation of the innate immune system is proinflammatory in the prehypertensive spontaneously hypertensive rat, a genetic model of essential hypertension”. Circ Res 111(9) (2012), pp. 1190–1197. DOI: https://doi.org/10.1161/CIRCRESAHA.112.277475. DOI: https://doi.org/10.1161/CIRCRESAHA.112.277475
S Khandelwal. “Obesity in midlife: lifestyle and dietary strategies”. Climacteric 23(2) (2020), pp. 140–147. DOI: https://doi.org/10.1080/13697137.2019.1660638. DOI: https://doi.org/10.1080/13697137.2019.1660638
T N Akbaraly et al. “Glycemia, insulin resistance, insulin secretion, and risk of depressive symptoms in middle age”. Diabetes Care 36(4) (2013), pp. 928–934. DOI: https://doi.org/10.2337/dc12-0239. DOI: https://doi.org/10.2337/dc12-0239
Tan Li et al. “TLR4 rs1927914 polymorphism contributes to serum TLR4 levels in patients with aortic aneurysm”. Exper Mol Pathol 119 (2021), p. 104609. DOI: https://doi.org/10.1016/j.yexmp.2021.104609. DOI: https://doi.org/10.1016/j.yexmp.2021.104609
Y S Song et al. “Comparison of the usefulness of the updated homeostasis model assessment (HOMA2) with the original HOMA1 in the prediction of type 2 diabetes mellitus in Koreans”. Diabetes Metab J 40(4) (2016), pp. 318–325. DOI: https://doi.org/10.4093/dmj.2016.40.4.318. DOI: https://doi.org/10.4093/dmj.2016.40.4.318
Y Zhang et al. “Association between serum resistin concentration and hypertension: A systematic review and meta-analysis”. Oncotarget 8(25) (2017), pp. 41529–41537. DOI: https://doi.org/10.18632/oncotarget.17561. DOI: https://doi.org/10.18632/oncotarget.17561
Yun Jiang et al. “Resistin induces hypertension and insulin resistance in mice via a TLR4-dependent pathway”. Sci Rep 6(1) (2016), pp. 1–7. DOI: https://doi.org/10.1038/srep22193. DOI: https://doi.org/10.1038/srep22193
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2021 Mustafa K. Al-Taie, Rayah S. Baban, Mouayed B. Hamed
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors retain all proprietary rights, including copyright, such as patent and trademark rights and rights to any process or procedure described in the article.
How to Cite
Share
